Works matching IS 13515101 AND DT 2018 AND VI 25


Results: 298
    1
    2
    3
    4
    5
    6

    MYOD1 involvement in myopathy.

    Published in:
    2018
    By:
    • Lopes, F.;
    • Miguet, M.;
    • Mucha, B. E.;
    • Gauthier, J.;
    • Saillour, V.;
    • Nguyen, C.‐T. É.;
    • Vanasse, M.;
    • Ellezam, B.;
    • Michaud, J. L.;
    • Soucy, J.‐F.;
    • Campeau, P. M.
    Publication type:
    Letter to the Editor
    7
    8
    9
    10

    Professional occupation and the risk of Parkinson's disease.

    Published in:
    European Journal of Neurology, 2018, v. 25, n. 12, p. 1470, doi. 10.1111/ene.13752
    By:
    • Darweesh, S. K. L.;
    • Ikram, M. K.;
    • Faber, M. J.;
    • de Vries, N. M.;
    • Haaxma, C. A.;
    • Hofman, A.;
    • Koudstaal, P. J.;
    • Bloem, B. R.;
    • Ikram, M. A.
    Publication type:
    Article
    11
    12
    13

    Study of the possible link of 25‐hydroxyvitamin D with Epstein–Barr virus and human herpesvirus 6 in patients with multiple sclerosis.

    Published in:
    European Journal of Neurology, 2018, v. 25, n. 12, p. 1446, doi. 10.1111/ene.13749
    By:
    • Pérez‐Pérez, S.;
    • Domínguez‐Mozo, M. I.;
    • García‐Martínez, M. Á.;
    • Aladro, Y.;
    • Martínez‐Ginés, M.;
    • García‐Domínguez, J. M.;
    • López de Silanes, C.;
    • Casanova, I.;
    • Ortega‐Madueño, I.;
    • López‐Lozano, L.;
    • Torrejón, M. J.;
    • Arroyo, R.;
    • Álvarez‐Lafuente, R.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Acute idiopathic optic neuritis: not always benign.

    Published in:
    European Journal of Neurology, 2018, v. 25, n. 11, p. 1378, doi. 10.1111/ene.13753
    By:
    • Deschamps, R.;
    • Gueguen, A.;
    • Lecler, A.;
    • Lecouturier, K.;
    • Lamirel, C.;
    • Bensa, C.;
    • Marignier, R.;
    • Vignal, C.;
    • Gout, O.
    Publication type:
    Article
    23
    24
    25

    Alcohol overuse and intracerebral hemorrhage: characteristics and long‐term outcome.

    Published in:
    European Journal of Neurology, 2018, v. 25, n. 11, p. 1358, doi. 10.1111/ene.13734
    By:
    • Avellaneda‐Gómez, C.;
    • Serra Martínez, M.;
    • Rodríguez‐Campello, A.;
    • Ois, Á.;
    • Cuadrado‐Godia, E.;
    • Giralt‐Steinhauer, E.;
    • Vivanco‐Hidalgo, R.;
    • Jiménez‐Conde, J.;
    • Gómez‐González, A.;
    • Ceballos Cerrajería, P.;
    • Zabalza de Torres, A.;
    • Mola‐Caminal, M.;
    • Soriano‐Tárraga, C.;
    • Roquer, J.
    Publication type:
    Article
    26
    27
    28

    Spread of dystonia in patients with idiopathic adult‐onset laryngeal dystonia.

    Published in:
    European Journal of Neurology, 2018, v. 25, n. 11, p. 1341, doi. 10.1111/ene.13731
    By:
    • Esposito, M.;
    • Fabbrini, G.;
    • Ferrazzano, G.;
    • Berardelli, A.;
    • Peluso, S.;
    • Cesari, U.;
    • Gigante, A. F.;
    • Bentivoglio, A. R.;
    • Petracca, M.;
    • Erro, R.;
    • Barone, P.;
    • Schirinzi, T.;
    • Eleopra, R.;
    • Avanzino, L.;
    • Romano, M.;
    • Scaglione, C. L.;
    • Cossu, G.;
    • Morgante, F.;
    • Minafra, B.;
    • Zibetti, M.
    Publication type:
    Article
    29

    Erratum.

    Published in:
    2018
    Publication type:
    Correction Notice
    30
    31
    32
    33
    34
    36
    37
    38
    39
    40
    41
    42
    43

    European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus.

    Published in:
    European Journal of Neurology, 2018, v. 25, n. 10, p. 1201, doi. 10.1111/ene.13728
    By:
    • Nobili, F.;
    • Arbizu, J.;
    • Bouwman, F.;
    • Drzezga, A.;
    • Agosta, F.;
    • Nestor, P.;
    • Walker, Z.;
    • Boccardi, M.;
    • the EANM‐EAN Task Force for the Prescription of FDG‐PET for Dementing Neurodegenerative Disorders
    Publication type:
    Article
    44
    45
    46
    47

    Clinical activity after fingolimod cessation: disease reactivation or rebound?

    Published in:
    European Journal of Neurology, 2018, v. 25, n. 10, p. 1270, doi. 10.1111/ene.13694
    By:
    • Frau, J.;
    • Sormani, M. P.;
    • Signori, A.;
    • Realmuto, S.;
    • Baroncini, D.;
    • Annovazzi, P.;
    • Signoriello, E.;
    • Maniscalco, G. T.;
    • La Gioia, S.;
    • Cordioli, C.;
    • Frigeni, B.;
    • Rasia, S.;
    • Fenu, G.;
    • Grasso, R.;
    • Sartori, A.;
    • Lanzillo, R.;
    • Stromillo, M. L.;
    • Rossi, S.;
    • Forci, B.;
    • Cocco, E.
    Publication type:
    Article
    48
    49
    50